Presence of circulating endothelial progenitor cells and levels of stromal-derived factor-1α are associated with ascending aorta aneurysm size

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages

  Parietti, Eric ^a   Pallandre, Jean René ^b   Deschaseaux, Frederic ^b   Aupècle, Bertrand ^a   Durst, Camille ^a   Kantelip, Jean Pierre ^a   Chocron, Sidney ^a   Davani, Siamak ^a  

^a Bâtiment Socrate   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Aneurysm; Ascending thoracic aortic; Biomarker; Endothelial progenitor cells; SDF 1

Indexed keywords

ANTIHYPERTENSIVE AGENT; CD14 ANTIGEN; CD34 ANTIGEN; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANEURYSM SURGERY; ANTIHYPERTENSIVE THERAPY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERTENSION; IDIOPATHIC ASCENDING THORACIC AORTA ANEURYSM; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL PATIENT; THORACIC AORTA ANEURYSM;

AGED; ANTIGENS, CD; AORTIC ANEURYSM; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CELL MOVEMENT; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; STEM CELLS;

EID: 79957998373     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.02.065     Document Type: Article

References (25)

1. Elefteriades J.A., Farkas E.A. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol 2010, 55:841-857.
2. Clouse W.D., Hallett J.W., Schaff H.V., Gayari M.M., Ilstrup D.M., Melton L.J. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 1998, 280:1926-1929.
3. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Jr., Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010;121:e266-369.
4. Brunner S., Engelmann M.G., Franz W.M. Stem cell mobilisation for myocardial repair. Expert Opin Biol Ther 2008, 8:1675-1690.
5. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
6. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-7.
7. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Bohm M., Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
8. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner J.M., Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
9. Deschaseaux F., Selmani Z., Falcoz P.E., Mersin N., Meneveau N., Penfornis A., Kleinclauss C., Chocron S., Etievent J.P., Tiberghien P., Kantelip J.P., Davani S. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol 2007, 562:111-118.
10. Dawson J., Tooze J., Cockerill G., Choke E., Loftus I., Thompson M.M. Endothelial progenitor cells and abdominal aortic aneurysms. Ann N Y Acad Sci 2006, 1085:327-330.
11. Sho E., Sho M., Nanjo H., Kawamura K., Masuda H., Dalman R.L. Hemodynamic regulation of CD34+ cell localization and differentiation in experimental aneurysms. Arterioscler Thromb Vasc Biol 2004, 24:1916-1921.
12. Romagnani P., Annunziato F., Liotta F., Lazzeri E., Mazzinghi B., Frosali F., Cosmi L., Maggi L., Lasagni L., Scheffold A., Kruger M., Dimmeler S., Marra F., Gensini G., Maggi E., Romagnani S. CD14+CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005, 97:314-322.
13. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
14. Chan J.Y., Watt S.M. Adhesion receptors on haematopoietic progenitor cells. Br J Haematol 2001, 112:541-557.
15. Leone A.M., Valgimigli M., Giannico M.B., Zaccone V., Perfetti M., D'Amario D., Rebuzzi A.G., Crea F. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 2009, 30:890-899.
16. Numaguchi Y., Sone T., Okumura K., Ishii M., Morita Y., Kubota R., Yokouchi K., Imai H., Harada M., Osanai H., Kondo T., Murohara T. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006, 114:I114-I119.
17. Schmidt-Lucke C., Rossig L., Fichtlscherer S., Vasa M., Britten M., Kamper U., Dimmeler S., Zeiher A.M. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
18. Van Craenenbroeck E.M., Beckers P.J., Possemiers N.M., Wuyts K., Frederix G., Hoymans V.Y., Wuyts F., Paelinck B.P., Vrints C.J., Conraads V.M. Exercise acutely reverses dysfunction of circulating angiogenic cells in chronic heart failure. Eur Heart J 2010, 31:1924-1934.
19. Sibal L., Aldibbiat A., Agarwal S.C., Mitchell G., Oates C., Razvi S., Weaver J.U., Shaw J.A., Home P.D. Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 2009, 52:1464-1473.
20. Schmidt-Lucke C., Fichtlscherer S., Aicher A., Tschope C., Schultheiss H.P., Zeiher A.M., Dimmeler S. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 2010, 5:e13790.
21. Cecyn K.Z., Schimieguel D.M., Kimura E.Y., Yamamoto M., Oliveira J.S. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors. Transfus Apher Sci 2009, 40:159-167.
22. Xiao Q., Ye S., Oberhollenzer F., Mayr A., Jahangiri M., Willeit J., Kiechl S., Xu Q. SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study. PLoS One 2008, 3:e4061.
23. Damas J.K., Waehre T., Yndestad A., Ueland T., Muller F., Eiken H.G., Holm A.M., Halvorsen B., Froland S.S., Gullestad L., Aukrust P. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002, 106:36-42.
24. Wojakowski W., Kucia M., Kazmierski M., Ratajczak M.Z., Tendera M. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?. Heart 2008, 94:27-33.
25. Ratajczak M.Z., Lee H., Wysoczynski M., Wan W., Marlicz W., Laughlin M.J., Kucia M., Janowska-Wieczorek A., Ratajczak J. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010, 24:976-985.